larixol은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

larixol은 임신 중 안전한가요?

No harmonised CLP classification (no H360/H361), no SCCS or CIR safety assessment located, and no reproductive or developmental toxicity data in PubMed for larixol. Available sources describe pharmacology (TRPC6/fMLP activity) but not teratogenic or reproductive effects; supplier SDSs list no GHS reproductive hazard. (PubMed studies; supplier SDS; ECHA search showing no harmonised classification).

larixol은 모유 수유 중 안전한가요?

No data indicating reproductive/developmental or lactation-specific toxicity, no harmonised classification, and no regulatory safety assessment (SCCS/CIR) raising concern. Peer‑reviewed literature describes TRPC6 and immunomodulatory activity but not effects on lactation or milk transfer. (PubMed; supplier SDS; ECHA/C&L checks).

larixol은 아기 피부에 안전한가요?

No evidence of a reproductive or developmental hazard specific to infants. Dermal absorption data for larixol were not found; as a moderately lipophilic diterpenoid used at low concentrations in formulations (patent/product listings), systemic exposure from cosmetic topical use appears low for adults (scored e=0). Per instructions, infant skin has higher absorption potential, so exposure score increased by +1 for babies (e=1) in absence of data. No infant-specific toxicity data were found. (Patents/product listings; supplier pages; absence of SCCS/CIR).

VeriMom은 larixol을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 larixol을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 larixol 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.